Cargando…
Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer Patients
Oral mucositis (OM) is among the most undesirable, painful, and expensive toxicities of cytotoxic cancer therapy, and is disheartening for patients and frustrating for caregivers. Accurate assessment of the incidence of OM has been elusive, but accumulating data suggests that reported OM frequency i...
Autores principales: | Bonomi, Marcelo, Batt, Katharine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586795/ https://www.ncbi.nlm.nih.gov/pubmed/26404378 http://dx.doi.org/10.3390/cancers7030862 |
Ejemplares similares
-
Morphine mouthwash for the management of oral mucositis in patients with head and neck cancer
por: Sarvizadeh, Mostafa, et al.
Publicado: (2015) -
Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients
por: Kudrimoti, Mahesh, et al.
Publicado: (2017) -
Management of Chemoradiation-Induced Mucositis in Head and Neck Cancers With Oral Glutamine
por: Pattanayak, Lucy, et al.
Publicado: (2016) -
Mucosal Pain Disorders of the Head and Neck
por: Eversole, Lewis R.
Publicado: (1989) -
Narrative review of the management of oral mucositis during chemoradiation for head and neck cancer
por: Judge, Lauren F., et al.
Publicado: (2021)